New Study Shows 2-HOBA Supports Immune Function

woman scientist in a lab testing matrials

a line of test tubes with blood in them
NEW Study Shows 2-HOBA Supplementation has a Promising Impact on Immune Health.

TSI Group is proud to announce positive results from a recent NIH-funded study on the impact of 2-hydroxybenzylamine (2-HOBA), TSI’s branded ingredient Hobamine, on inflammatory biomarkers.

Balance is Essential to a Proactive Approach to Immune Health

The NIH-funded study, published in the journal Inflammation, found that supplementing with 2-HOBA improved as many as 15 inflammatory biomarkers in healthy individuals, thereby promoting a healthy balance of the immune system.

“Normally, inflammation is self-limiting, and its resolution is the first step in the repair and regeneration of injured tissues. Failure of inflammation resolution can lead to the progression of several diseases,” says John A. Rathmacher, Ph.D., Director of Clinical Research and Laboratory Services at MTI BioTech, Inc. That’s why a balanced immune system is incredibly important.

Opportunities for Immune Formulations

“These results enable us to enter a new space in immune health and will guide us in future research,” comments TSI Group Vice President of Business Development Shawn Baier, M.S., M.B.A. “More significantly, this opens opportunities for formulators and developers to add Hobamine to their immune formulas because it clearly enables healthy individuals to be more proactive about maintaining their immune readiness.”

This concept of immune readiness is perhaps what Baier finds most exciting. “If you don’t have 2-HOBA present, and your body creates these highly-reactive, proinflammatory compounds, it could begin an unhealthy snowball effect. Having 2-HOBA on board means it’s ready and there when it’s needed. It supports your immune system’s ability to stay in balance, even when you are exposed to oxidative stressors.”

Read the study or correlating articles below.

Share Post:

More From
The Blog


A Year in Review

Hobamine has claimed the spotlight in the field of cellular health this past year, and TSI Group eagerly anticipates the developments in 2024. Hobamine, TSI Group’s latest ingredient breakthrough, has garnered recognition as one of the standout discoveries of the year. As we take pride in reflecting on the past year, we eagerly anticipate exploring new studies and findings that await on the horizon. But first, let’s revisit some notable highlights from 2023.     New Study Shows 2-HOBA has a Promising Impact on Immune Health In a study funded by the NIH and published in the journal Inflammation, it

Read More »
bring your best to immune health by leading a healthy lifestyle.

The Importance of Immune Health

In Nutraceuticals World an article Immune Health Remains a Top Priority, Even as Many Move on from Covid, highlights the importance of immune health and how new supplement formulas offer great value to consumers. Despite a 4.3% decline in sales for immune health supplements in the last year, the category remains relevant. The decline is slowing, and experts believe it won’t plummet to the levels seen after the pandemic’s peak. One significant challenge faced by manufacturers, vendors, and retailers is dealing with overstock issues as they stocked up on immune products during the pandemic. However, this overstock situation has opened

Read More »

The Cellular Health Market

In Nutritional Outlook, industry leaders give their expert advice on the trends that are driving the cellular health market. The cellular health industry continues to grow with more and more ingredients coming to the forefront.  As this category evolves, it’s hard for consumers to navigate the market.  Brands need to step up their game to educate consumers on the science behind these ingredients. New Developments in Cellular Health “Aging research has evolved in recent years,” says Aileen Stocks, president of wellness brands at Nestlé Health Science. “Researchers now know there is a time-related decline of several cellular mechanisms that often

Read More »